Coronavirus latest: Japan plans 10,000 random antibody tests

The Nikkei Asian Review is tracking the spread of the new coronavirus that originated in the central Chinese city of Wuhan.

Global cases have reached 5,101,400, according to Johns Hopkins University.

The worldwide death toll has hit 332,876.

To see how the disease has spread, view our virus tracker charts:

(Source photo by AP) 

Here are the latest developments (Tokyo time):

Friday, May 22

11:00 a.m. Japan’s health minister says the country will begin checking people to see if they have had the virus, with 10,000 antibody tests to be conducted in Tokyo, Osaka and Miyagi prefectures starting

Read More

Singapore pushes ‘one hour’ coronavirus antibody tests for export

SINGAPORE — Rapid test kits unveiled in Singapore on Friday promise to help governments worldwide assess the true spread of the coronavirus and the extent of public immunity.

The kits, called cPass, were developed after trials on COVID-19 patients in China and the city-state. They signal whether a subject has developed antibodies, or a biological response to fight the disease. This would mean they were infected at some point.

The process takes only an hour, according to the public-private venture behind the technology.

The makers — Singapore’s Duke-NUS Medical School, the city-state’s Agency for Science, Technology and Research, and Hong

Read More

Kao shares rise on coronavirus antibody findings

TOKYO — Shares of Japanese household goods maker Kao rose on Thursday after the company said it has jointly developed an antibody that suppresses new coronavirus infections.

The VHH antibody developed by the partnership is derived from camelids that are one-tenth the size of conventional antibodies and less costly to produce.

Kao, along with researchers at Kitasato University and Japanese biotech startup Epsilon Molecular Engineering, said they hope the findings will lead to the development of drugs for treating coronavirus infections.

The maker drew on experience with culturing microorganisms for detergents. In the joint study, Kao used technology from the

Read More

India halts China-made antibody tests after suspect results

NEW DELHI — India’s top medical research body has asked the country’s states to stop using Chinese-made coronavirus antibody tests for two days following reports of doubtful reliability.

Chinese manufacturers Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics supplied these testing kits and are now being investigated by the Indian Council of Medical Research, according to media reports.

The move comes as the Indian subsidiary of South Korean firm SD Biosensor starts production of antibody test kits at its plant in the northern state of Haryana, with a capacity to manufacture 500,000 per week.

India’s complaint follows reports of other countries,

Read More